BREATHE RIGHT NASAL STRIPS (ADVANCED & EXTRA)
Report
- Report Number
- 3004486989-2010-00003
- Event Type
- Other
- Date Received
- December 6, 2010
- Manufacturer
- GLAXOSMITHKLINE
- Product Code
- LWF
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- NOT APPLICABLE
Narratives
BREATHE RIGHT NASAL STRIPS ARE MANUFACTURED IN (B)(4). THE LOT NUMBER OF BREATHE RIGHT NASAL STRIPS ADVANCED IS KNOWN WHILE THE LOT NUMBER OF BREATHE RIGHT EXTRA NASAL STRIPS IS NOT KNOWN. IT IS UNK WHETHER THE PRODUCTS WILL BE SENT FOR QUALITY ASSURANCE TESTING. (B)(4). ADD'L LOT# UNK.
THIS CASE WAS REPORTED BY A CONSUMER AND DESCRIBED THE OCCURRENCE OF EXACERBATION OF SLEEP APNEA IN A MALE PT WHO RECEIVED BREATHE RIGHT NASAL STRIPS (BREATHE RIGHT NASAL STRIPS ADVANCED) FOR AN UNK DRUG INDICATION. A PHYSICIAN OR OTHER HEALTH CARE PROFESSIONAL HAS NOT VERIFIED THIS REPORT. CONCURRENT MEDICAL CONDITIONS INCLUDED MILD SLEEP APNEA. CO-SUSPECT MEDICATION INCLUDED BREATHE RIGHT NASAL STRIPS EXTRA. ON AN UNK DATE, THE PT STARTED BREATHE RIGHT NASAL STRIPS (TOPICAL). AT AN UNK TIME AFTER STARTING BREATHE RIGHT NASAL STRIPS, THE PT EXPERIENCED EXACERBATION OF SLEEP APNEA DESCRIBED AS A COMPLETE APNEA WHERE HE STOPPED BREATHING. THE PT ALSO REPORTED THAT HE EXPERIENCED ON ONE OCCASION HE EXPERIENCED A MOMENTARY PARALYSIS, INABILITY TO MOVE FOR 4 TO 5 SECONDS. ON AN UNK DATE, THE PT STARTED THE BREATHE RIGHT EXTRA NASAL STRIPS. AT AN UNK TIME AFTER STARTING BREATHE RIGHT EXTRA NASAL STRIPS, THE PT EXPERIENCED EXACERBATION OF HIS SLEEP APNEA, BUT TO A LESSER DEGREE THAN WHEN USING THE ADVANCED VARIANT. THIS CASE WAS ASSESSED AS MEDICALLY SERIOUS BY (B)(4). TREATMENT WITH BREATHE RIGHT NASAL STRIPS WAS DISCONTINUED. AT THE TIME OF REPORTING, THE EVENTS HAD RESOLVED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | BREATHE RIGHT NASAL STRIPS (ADVANCED & EXTRA) | NASAL STRIP | LWF | GLAXOSMITHKLINE | 251603UUF10 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |